SLC1A5 and breast cancer: As shown in S11 Fig, qPCR analysis performed at two different time points, 48h and 72h, indicated an up-regulation of Slc1a5, GOT1 and IDH1 at 72h in FSK treated samples, hence confirming also in human breast cancer cells a role of PKA activation in glutamine metabolism.